What is INRange Systems?
INRange Systems specializes in providing a cost-effective, comprehensive solution for First Dosing and E-Kit requirements within the pharmaceutical industry. Their EMMA E-Kit system offers granular control over individual unit doses of narcotics and robust inventory management for non-narcotics. By integrating advanced hardware and software with contemporary web and mobile technologies, INRange Systems aims to substantially reduce the operational costs associated with medication management, aligning with current technological expectations and efficiencies.
How much funding has INRange Systems raised?
INRange Systems has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for INRange Systems?
With the recent major strategic investment, INRange Systems is poised for accelerated growth and enhanced market penetration. This capital is expected to fuel further development of their EMMA E-Kit technology, potentially expanding its application across broader healthcare segments or enhancing its feature set. The company's focus on cost reduction and advanced inventory control positions it as a key player in optimizing pharmaceutical logistics and patient safety. Future initiatives will likely involve scaling operations, forging new strategic partnerships, and continuing to innovate in the digital health space.
See full INRange Systems company page
